Skip to main content

Cipla 25 mg 385 Pill - yellow capsule/oblong, 22mm

Pill with imprint Cipla 25 mg 385 is Yellow, Capsule/Oblong and has been identified as Lenalidomide 25 mg. It is supplied by Cipla USA, Inc.

Lenalidomide is used in the treatment of Multiple Myeloma; Lymphoma; Myelodysplastic Diseases; Follicular Lymphoma; Mantle Cell Lymphoma and belongs to the drug classes miscellaneous antineoplastics, other immunosuppressants. Not for use in pregnancy. Lenalidomide 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Cipla 25 mg 385

Lenalidomide 25 mg Cipla 25 mg 385

Lenalidomide

Imprint
Cipla 25 mg 385
Strength
25 mg
Color
Yellow
Size
22.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Miscellaneous antineoplastics, Other immunosuppressants
Pregnancy Category
X - Not for use in pregnancy
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA, Inc.
Manufacturer
Genvion Corporation
National Drug Code (NDC)
69097-0385

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.